View by Specialty

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Pediatric Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 10, 2023
2 min read
Save

Study sees link between lithium in water and autism that ‘requires further scrutiny’

Study sees link between lithium in water and autism that ‘requires further scrutiny’

A study of more than 50,000 children born over a 14-year period in Denmark found that children born to mothers who were exposed to higher levels of lithium in their drinking water were moderately more likely to develop autism.

SPONSORED CONTENT
March 30, 2023
2 min read
Save

Pitolisant safe, improved symptoms of narcolepsy in children

Pitolisant safe, improved symptoms of narcolepsy in children

Treatment with pitolisant demonstrated significant efficacy in reducing excessive daytime sleepiness and cataplexy in children aged 6 years and older, according to research presented in The Lancet Neurology.

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

SPONSORED CONTENT
March 28, 2023
1 min read
Save

Gene transfer therapy safe, efficacious for children with Duchenne muscular dystrophy

Gene transfer therapy safe, efficacious for children with Duchenne muscular dystrophy

Delandistrogene moxeparvovec improved motor function and was well-tolerated 4 years after treatment in a small cohort of children with Duchenne muscular dystrophy, according to a poster at the 2023 MDA Clinical & Scientific Conference.

SPONSORED CONTENT
March 22, 2023
1 min read
Save

Givinostat improved mobility, physical function in boys with Duchenne muscular dystrophy

Givinostat improved mobility, physical function in boys with Duchenne muscular dystrophy

Treatment with givinostat was associated with improvement in mobility and physical function compared with placebo in ambulant boys with Duchenne muscular dystrophy, according to a poster at the 2023 MDA Clinical & Scientific Conference.

SPONSORED CONTENT
March 20, 2023
1 min read
Save

FDA allows higher dose of investigational drug in study of children with Dravet syndrome

FDA allows higher dose of investigational drug in study of children with Dravet syndrome

Stoke Therapeutics Inc. announced the FDA will allow administration of a higher single dose of its investigational drug STK-001 in its ongoing phase 1/2a MONARCH study of children and adolescents with Dravet syndrome.

SPONSORED CONTENT
March 17, 2023
4 min read
Save

Q&A: Hyperbaric oxygen therapy improves cognitive function in children after concussion

Q&A: Hyperbaric oxygen therapy improves cognitive function in children after concussion

Results of a randomized, double-blind trial showed that hyperbaric oxygen therapy improved cognitive and behavioral function in children experiencing persistent post-concussion syndrome, as published in Scientific Reports.

SPONSORED CONTENT
March 14, 2023
2 min read
Save

Patients with pigmentary mosaicism exhibit low rates of neurological abnormalities

Patients with pigmentary mosaicism exhibit low rates of neurological abnormalities

Neurological abnormalities were not highly associated with pigmentary mosaicism, with only 14.8% of patients with the disorder exhibiting developmental delay, seizures or microcephaly, according to a study.

SPONSORED CONTENT
March 07, 2023
1 min read
Save

Multiple demand network ‘online early,’ sensitive to ability in young children

Multiple demand network ‘online early,’ sensitive to ability in young children

Regions of the brain associated with executive function in adults are similarly recruited in children as young as 4 years, according to findings published in the Journal of Neuroscience.

SPONSORED CONTENT
February 17, 2023
1 min read
Save

FDA approves Lamzede for non-CNS alpha-mannosidosis in adults, children

FDA approves Lamzede for non-CNS alpha-mannosidosis in adults, children

The FDA has approved Lamzede, an enzyme replacement therapy for non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients, Chiesi Global Rare Diseases announced in a press release.

SPONSORED CONTENT
February 08, 2023
2 min read
Save

Disparities in adversity linked to differences in brain structure of Black, white children

Disparities in adversity linked to differences in brain structure of Black, white children

Black children on average undergo more family conflict, material hardship and traumatic events than white children, resulting in differences in gray matter volume in key brain regions and disorders such as PTSD, data show.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails